Infectious complications caused by carbapenemase-producing Enterobacterales in patients with hematological disorders
Mortality rates approaching 60 % have been reported in hematological patients with infections caused by carbapenemase-producing Enterobacterales. The incidence of these infections is rapidly increasing, whereas the therapeutic options are limited. This review represents characteristics of infections...
Saved in:
Main Authors: | K. S. Tandilova, G. A. Klyasova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-10-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/373 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Factors for Non-Carbapenemase-Producing Carbapenem-Resistant <i>Enterobacterales</i> Infections: A Retrospective Cohort Study
by: Sayaka Mabuchi, et al.
Published: (2025-05-01) -
Clinical outcomes of phenotype-guided treatment in group D carbapenemase-producing Enterobacterales bacteremia
by: Jinghao Nicholas Ngiam, et al.
Published: (2025-07-01) -
Susceptibility of Gramnegative Carbapenemase-Producing Bacteria to Various Group Antibiotics
by: V. A. Ageevets, et al.
Published: (2020-05-01) -
Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization
by: S. V. Yakovlev, et al.
Published: (2020-08-01) -
Activity of aztreonam-avibactam and ceftazidime-avibactam against β-lactamase-producing enterobacterales Isolates from United States hospitals
by: Lalitagauri M Deshpande, et al.
Published: (2025-09-01)